Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Formula: C15H15NO
AG14361 (30 mg/kg) synergizes lestaurtinib activity on inhibiting breast cancer tumors in allografts
VH 032 amide alkylC5 acid
4r)-cyclohexane-1
NS-304 Size:Solid 2 mg A combat with the YAP/TAZ-TEADSelexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62
US$ 135.95
US$ 71.25
US$ 89.99
US$ 89.00